Skip to main content

Advertisement

Fig. 6 | BMC Systems Biology

Fig. 6

From: How to prevent viremia rebound? Evidence from a PRRSv data-supported model of immune response

Fig. 6

Immune mechanism efficacies discriminating between uniphasic and biphasic viremia profiles. Immune mechanism efficacies discriminating between uniphasic and biphasic viremia profiles. Efficacies of mechanisms known to affect the viral dynamics directly: a cell infection, c-e elimination of infected cells, f neutralisation; or indirectly: b apoptosis of naive target cells. Mean value and standard deviation of the 35 representative individuals selected for the uniphasic (green) and biphasic (red) profiles. p-value <1% when comparing uniphasic and biphasic profiles (Kolmogorov–Smirnov tests over two time periods: 0-20, 21–42 days)

Back to article page